Evidence map›Paper›PMID 33724150›Full record

ArticleCell adhesion & migration2021

The Netrin-1-Neogenin-1 signaling axis controls neuroblastoma cell migration via integrin-β1 and focal adhesion kinase activation.

Andrea A Villanueva, Pilar Sanchez-Gomez, Ernesto Muñoz-Palma, Sofía Puvogel, Bárbara S Casas, Cecilia Arriagada, Isaac Peña-Villalobos, Pablo Lois, Manuel Ramírez Orellana, Fabiana Lubieniecki and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell adhesion & migration, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Netrin-1 Is an Important Mediator in Microglia Migration.International journal of molecular sciences · 2024
    Article
  8. Netrin-1 as A neural guidance protein in development and reinnervation of the larynx.Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Netrin-1 in Glioblastoma Neovascularization: The New Partner in Crime?International journal of molecular sciences · 2021
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Andrea A VillanuevaLaboratory of Stem Cells and Developmental Biology, Faculty of Sciences. Universidad de Chile, Santiago, Chile.
Pilar Sanchez-GomezNeurooncology Unit, Unidad Funcional de Investigación en Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Ernesto Muñoz-PalmaLaboratory of Stem Cells and Developmental Biology, Faculty of Sciences. Universidad de Chile, Santiago, Chile.ORCID 0000-0002-2938-3944
Sofía PuvogelLaboratory of Stem Cells and Developmental Biology, Faculty of Sciences. Universidad de Chile, Santiago, Chile.
Bárbara S CasasLaboratory of Stem Cells and Developmental Biology, Faculty of Sciences. Universidad de Chile, Santiago, Chile.
Cecilia ArriagadaInstitute for Research in Dental Sciences, Faculty of Dentistry, Universidad de Chile, Olivos 943, Independencia, Santiago, Chile.
Isaac Peña-VillalobosLaboratory of Stem Cells and Developmental Biology, Faculty of Sciences. Universidad de Chile, Santiago, Chile.
Pablo LoisPostgraduate in Education Department, Faculty of Humanities, Universidad Mayor. Santiago, Chile.
Manuel Ramírez OrellanaPostgraduate in Education Department, Faculty of Humanities, Universidad Mayor. Santiago, Chile.ORCID 0000-0003-0332-6973
Fabiana LubienieckiHospital de Pediatría Dr. Prof. Juan P. Garrahan, Buenos Aires, Argentina.
Fernando Casco ClaroUnidad Anatomía Patológica, Unilabs, Madrid, España.
Iván GallegosUniversidad de Chile, Universidad de Chile, Santiago, Chile.
Javier García-CastroCellular Biotechnology Unit, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III, ISCIII, Madrid, Spain.
Vicente A TorresInstitute for Research in Dental Sciences, Faculty of Dentistry, Universidad de Chile, Olivos 943, Independencia, Santiago, Chile.ORCID 0000-0002-0709-4973
Verónica PalmaLaboratory of Stem Cells and Developmental Biology, Faculty of Sciences. Universidad de Chile, Santiago, Chile.ORCID 0000-0002-4320-7525
University of Chile · CLInstituto de Salud Carlos III · ESUniversidad Mayor · CLGarrahan Hospital · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroblastoma is a highly metastatic tumor that emerges from neural crest cell progenitors. Focal Adhesion Kinase (FAK) is a regulator of cell migration that binds to the receptor Neogenin-1 and is upregulated in neuroblastoma. Here, we show that Netrin-1 ligand binding to Neogenin-1 leads to FAK autophosphorylation and integrin β1 activation in a FAK dependent manner, thus promoting neuroblastoma cell migration. Moreover, Neogenin-1, which was detected in all tumor stages and was required for neuroblastoma cell migration, was found in a complex with integrin β1, FAK, and Netrin-1. Importantly, Neogenin-1 promoted neuroblastoma metastases in an immunodeficient mouse model. Taken together, these data show that Neogenin-1 is a metastasis-promoting protein that associates with FAK, activates integrin β1 and promotes neuroblastoma cell migration.

Indexed as

Integrin beta1NeuroblastomaAnimalsCell AdhesionCell MovementFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesMembrane ProteinsMiceNetrin-1Focal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesIntegrin beta1Membrane ProteinsneogeninNetrin-1FAK; cell migrationintegrin-β1 activationmetastasisNeogenin-1Netrin-1neuroblastoma

Identifiers

PMID33724150
PMCPMC7971226
OpenAlexW3137026955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.